Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1965;33(4):557–566.

Evaluation of the treatment of human Schistosoma mansoni infection by the quantitative oogram technique*

J Romeu Cançado, A Sales da Cunha, D Garcia de Carvalho, J N Santos Cambraia
PMCID: PMC2475897  PMID: 5323117

Abstract

Egg output is the only measure available for quantitative assessment of the activity of chemotherapeutic agents in Schistosoma mansoni infection. In the light of eight years' experience in the preparations of oograms, the authors suggest a simplified classification of S. mansoni eggs and certain improvements in the oogram technique by which quantitative data are obtained for comparison before and after treatment.

Ten cases, taken from clinical trials on a variety of schistosomicidal compounds, are presented to illustrate the use of the quantitative oogram and the types of result obtained with active, partially active and inactive drugs.

Full text

PDF
559

Images in this article

558-3FIG. 3
on p.558-3
558-2FIG. 2
on p.558-2
558-1FIG. 1
on p.558-1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALVES W., HARPER J., HILL J. Preliminary field trials with M&B 2948A in Schistosoma haematobium infections in man. Trans R Soc Trop Med Hyg. 1961 Jan;55:40–43. doi: 10.1016/0035-9203(61)90036-0. [DOI] [PubMed] [Google Scholar]
  2. BUEDING E. Carbohydrate metabolism of schistosoma mansoni. J Gen Physiol. 1950 May 20;33(5):475–495. doi: 10.1085/jgp.33.5.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BUEDING E. Mechanisms of action of schistosomicidal agents. J Pharm Pharmacol. 1959 Jul;11:385–392. doi: 10.1111/j.2042-7158.1959.tb12570.x. [DOI] [PubMed] [Google Scholar]
  4. BURNETT H. S., WAGNER E. D. Tris(p-aminophenyl) carbonium salts in the treatment of schistosomiasis in Nyasaland. Am J Trop Med Hyg. 1961 Jul;10:547–550. doi: 10.4269/ajtmh.1961.10.547. [DOI] [PubMed] [Google Scholar]
  5. COLLINS R. F., DAVIS M., EDGE N. D., HILL J., READING H. W., TURNBULL E. R. The schistosomicidal and toxic effects of some N-p-aminophenoxyalkylamides. Br J Pharmacol Chemother. 1959 Dec;14:467–476. doi: 10.1111/j.1476-5381.1959.tb00950.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. ELSLAGER E. F., SHORT F. W., WORTH D. F., MEISENHELDER J. E., NAJARIAN H., THOMPSON P. E. Effects of tris(paminophenyl)-carbonium salts and related compounds on experimental schistosomiasis and paragonimiasis. Nature. 1961 May 13;190:628–629. doi: 10.1038/190628a0. [DOI] [PubMed] [Google Scholar]
  7. GELFAND M., REID E. T., SIMPSON B. E. A trial with dehydro-emetine in schistosomiasis in Rhodesia. Trans R Soc Trop Med Hyg. 1962 Jan;56:77–80. doi: 10.1016/0035-9203(62)90093-7. [DOI] [PubMed] [Google Scholar]
  8. HITMAN D. K., WAGNER E. D. The treatment of urinary schistosomiasis in Kenya and Nigeria with tris (p-aminophenyl) carbonium pamoate. Trans R Soc Trop Med Hyg. 1962 Sep;56:386–389. doi: 10.1016/0035-9203(62)90010-x. [DOI] [PubMed] [Google Scholar]
  9. KIKUTH W., GONNERT R. Experimental studies on the therapy of schistosomiasis. Ann Trop Med Parasitol. 1948 Dec;42(3-4):256–267. doi: 10.1080/00034983.1948.11685374. [DOI] [PubMed] [Google Scholar]
  10. LARIVIERE M., HOCQUET P., MICHEL R. [Study of the activity of 1-(p-aminophenoxy)-5-phthalimidopentane (RP-6171) on human bilharziasis caused by S. haematobium and S. mansoni]. Bull Soc Pathol Exot Filiales. 1960 Nov-Dec;53:996–1010. [PubMed] [Google Scholar]
  11. MANSOUR T. E., BUEDING E. The actions of antimonials on glycolytic enzymes of Schistosoma mansoni. Br J Pharmacol Chemother. 1954 Dec;9(4):459–462. doi: 10.1111/j.1476-5381.1954.tb00861.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MOORE D. V., SANDGROUND J. H. The relative egg producing capacity of Schistosoma mansoni and Schistosoma japonicum. Am J Trop Med Hyg. 1956 Sep;5(5):831–840. doi: 10.4269/ajtmh.1956.5.831. [DOI] [PubMed] [Google Scholar]
  13. PELLEGRINO J., OLIVEIRA C. A., FARIA J., CUNHA A. S. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg. 1962 Mar;11:201–215. doi: 10.4269/ajtmh.1962.11.201. [DOI] [PubMed] [Google Scholar]
  14. PEREIRA O. A., NETTO M. B. Biópsia retal múltipla e oograma na esquistomose mansoni. Arq Clin (Rio De J) 1949 Sep-Oct;9(3-4):127-53, tab. [PubMed] [Google Scholar]
  15. SCHNEIDER J., SANSARRICQ H. [The anti-bilharzial activity of N-(p-amsinophenoxy)-5-phthalimidopentane (RP 6171). Apropos of 43 cases of vesical bilharziasis caused by Schistoma haematobium]. Med Trop (Mars) 1959 Jul-Aug;19:412–424. [PubMed] [Google Scholar]
  16. STANDEN O. D. Experimental schistosomiasis. III. Chemotherapy and mode of drug action. Ann Trop Med Parasitol. 1953 Mar;47(1):26–43. [PubMed] [Google Scholar]
  17. STANDEN O. D. The treatment of experimental schistosomiasis in mice; sexual maturity and drug response. Ann Trop Med Parasitol. 1955 Jun;49(2):183–192. doi: 10.1080/00034983.1955.11685665. [DOI] [PubMed] [Google Scholar]
  18. THOMPSON P. E., MEISENHELDER J. E., NAJARIAN H. Laboratory studies on the effects of tris(p-aminophenyl)-carbonium salts, tris(p-aminophenyl)methanol, and lucanthone hydrochloride against Schistosoma mansoni. Am J Trop Med Hyg. 1962 Jan;11:31–45. doi: 10.4269/ajtmh.1962.11.31. [DOI] [PubMed] [Google Scholar]
  19. VOGEL H., MINNING W. The action of miracil in Schistosoma japonicum infections in laboratory animals. Ann Trop Med Parasitol. 1948 Dec;42(3-4):268–270. doi: 10.1080/00034983.1948.11685375. [DOI] [PubMed] [Google Scholar]
  20. da CUNHA A. [Scraping of the rectal mucosa with a curet in the diagnosis of schistosomiasis mansoni. Comparison between the oogram of the scraping and the rectal biopsy]. Hospital (Rio J) 1962 Apr;61:835–854. [PubMed] [Google Scholar]
  21. de GOUVEIA O., TEIXEIRA D. [Therapeutic trials of Ro 1-9334 in Manson's schistosomiasis]. Hospital (Rio J) 1963 Mar;63:639–653. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES